Procter & Gamble reported strong organic sales growth in nine out of ten categories and raised its organic sales guidance, reflecting robust performance despite ongoing cost pressures from commodities and foreign exchange. The positive outlook and strategic investments in innovation and capacity are likely to bolster investor confidence in the short term. However, the tempered EPS guidance due to cost headwinds may slightly offset the enthusiasm.

[1]